Figure 2.
PFS and OS of patients in the CTC subgroups (with 11 and 16 FU/3 mL as the cutoff threshold). (A,B) The Kaplan-Meier curve of PFS (A) and OS (B) of the entire cohort (n=98); (C,D) PFS (C) and OS (D) of the patients received >1 cycle of pemetrexed treatment (n=88). CTC, circulating tumor cell; FU, folate receptor unit; PFS, progression-free survival; OS, overall survival.